Exercise Based Rehabilitation & Strength Training Poseidon Performance Dartmouth Sublingual BPC 157 TruHealth Physical Therapy BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Examples of successful administration mechanisms for the delivery of Download Scientific Diagram Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS